SolarWindow (WNDW) 10-Q 10 Oct 23 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Feb. 28, 2023	Oct. 05, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Feb. 28, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--08-31
Entity File Number	333-127953
Entity Registrant Name	SOLARWINDOW TECHNOLOGIES, INC.
Entity Central Index Key	0001071840
Entity Tax Identification Number	59-3509694
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	9375 E. Shea Blvd.
Entity Address, Address Line Two	Suite 107-B
Entity Address, City or Town	Scottsdale
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85260
City Area Code	800
Local Phone Number	213-0689
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		53,198,399

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Feb. 28, 2023	Aug. 31, 2022
Current assets
Cash and cash equivalents	$ 1,065,611	$ 8,077,849
Short-term investments	6,000,000
Deferred research and development costs	52,396	153,799
Prepaid expenses and other current assets	199,813	87,232
Current assets of discontinued operations	14,085	43,599
Total current assets	7,331,905	8,362,479
Property and Equipment, net of accumulated depreciation of $117,940 and $110,418, respectively	1,322,470	1,329,992
Total assets	8,654,375	9,692,471
Current liabilities
Accounts payable and accrued expenses	93,154	60,791
Related party payables	30,333
Current liabilities of discontinued operations	105,490	57,585
Total current liabilities	228,977	118,376
Total liabilities	228,977	118,376
Commitments and contingencies
Stockholders' equity
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding
Common stock: $0.001 par value; 300,000,000 shares authorized, 53,198,399 shares issued and outstanding at February 28, 2023 and August 31, 2022	53,198	53,198
Additional paid-in capital	82,685,929	82,576,002
Accumulated other comprehensive income (loss)	(78,401)	(73,631)
Retained deficit	(74,235,328)	(72,981,474)
Total stockholders' equity	8,425,398	9,574,095
Total liabilities and stockholders' equity	$ 8,654,375	$ 9,692,471

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Feb. 28, 2023	Aug. 31, 2022
Statement of Financial Position [Abstract]
Property and Equipment, net of accumulated depreciation	$ 117,940	$ 110,418
Preferred stock, par value	$ 0.10	$ 0.10
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	53,198,399	53,198,399
Common stock, shares outstanding	53,198,399	53,198,399

CONSOLIDATED STATEMENTS OF OPE

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2023	Feb. 28, 2022
Income Statement [Abstract]
Revenue
Operating expenses
Selling, general and administrative	359,601	980,006	744,085	1,818,383
Research and development	180,301	197,959	396,867	500,208
Total operating expenses	539,902	1,177,965	1,140,952	2,318,591
Loss from operations	(539,902)	(1,177,965)	(1,140,952)	(2,318,591)
Other income (expense)
Interest income	49,595	1,177	91,608	12,101
Other income				13,560
Total other income (expense)	49,595	1,177	91,608	25,661
Net loss from continuing operations	(490,307)	(1,176,788)	(1,049,344)	(2,292,930)
Net loss from discontinued operations	(37,390)	(201,046)	(204,510)	(411,028)
Net loss	(527,697)	(1,377,834)	(1,253,854)	(2,703,958)
Other comprehensive income (loss)
Foreign currency translation gain/(loss)	661	(13,696)	(4,770)	(18,856)
Comprehensive income (loss)	$ (527,036)	$ (1,391,530)	$ (1,258,624)	$ (2,722,814)

CONSOLIDATED STATEMENTS OF O_2

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2023	Feb. 28, 2022
Income Statement [Abstract]
Loss per Share from continuing operations basic	$ (0.01)	$ (0.02)	$ (0.02)	$ (0.04)
Loss per Share from continuing operations diluted	(0.01)	(0.02)	(0.02)	(0.04)
Loss per Share from discontinued operations basic	0	0	0	(0.01)
Loss per Share from discontinued operations diluted	0	0	0	(0.01)
Loss per Share basic	(0.01)	(0.03)	(0.02)	(0.05)
Loss per Share diluted	$ (0.01)	$ (0.03)	$ (0.02)	$ (0.05)
Weighted average number of common shares outstanding - basic	53,198,399	53,198,399	53,198,399	53,198,399
Weighted average number of common shares outstanding - diluted	53,198,399	53,198,399	53,198,399	53,198,399

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Aug. 31, 2021	$ 53,198	$ 81,551,840	$ (14,872)	$ (68,032,941)	$ 13,557,225
Beginning balance, shares at Aug. 31, 2021	53,198,399
Stock based compensation due to common stock purchase options		278,863			278,863
Foreign currency translation adjustment			(5,160)		(5,160)
Net loss				(1,326,124)	(1,326,124)
Ending balance, value at Nov. 30, 2021	$ 53,198	81,030,703	(20,032)	(69,359,065)	12,504,804
Ending balance, shares at Nov. 30, 2021	53,198,399
Stock based compensation due to common stock purchase options		410,789			410,789
Foreign currency translation adjustment			(13,696)		(13,696)
Net loss				(1,377,834)	(1,377,834)
Ending balance, value at Feb. 28, 2022	$ 53,198	82,241,492	(33,728)	(70,736,899)	11,524,063
Ending balance, shares at Feb. 28, 2022	53,198,399
Beginning balance, value at Aug. 31, 2022	$ 53,198	82,576,002	(73,631)	(72,981,474)	9,574,095
Beginning balance, shares at Aug. 31, 2022	53,198,399
Stock based compensation due to common stock purchase options		85,200			85,200
Foreign currency translation adjustment			(5,431)		(5,431)
Net loss				(726,157)	(726,157)
Ending balance, value at Nov. 30, 2022	$ 53,198	82,661,202	(79,062)	(73,707,631)	8,927,707
Ending balance, shares at Nov. 30, 2022	53,198,399
Stock based compensation due to common stock purchase options		24,727			24,727
Foreign currency translation adjustment			661		661
Net loss				(527,697)	(527,697)
Ending balance, value at Feb. 28, 2023	$ 53,198	$ 82,685,929	$ (78,401)	$ (74,235,328)	$ 8,425,398
Ending balance, shares at Feb. 28, 2023	53,198,399

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Cash flows from operating activities
Net loss from continuing operations	$ (1,049,344)	$ (2,292,930)
Net loss from discontinued operations	(204,510)	(411,028)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation	7,521	15,809
Stock based compensation expense	109,927	689,652
Changes in operating assets and liabilities:
Deferred research and development costs	101,403	(16,514)
Prepaid expenses and other assets	(82,736)	(141,585)
Accounts payable and accrued expenses	47,244	80,026
Related party payable	58,762	(84,693)
Net cash used in operating activities	(1,011,733)	(2,161,263)
Cash flows from investing activities
Purchase of short-term investments	(6,000,000)
Redemption of short-term investments		5,000,000
Capital expenditures		(584,235)
Net cash provided by (used in) investing activities	(6,000,000)	4,415,765
Effect of exchange rate changes on cash and cash equivalents	(505)	(10,928)
Net increase (decrease) in cash and cash equivalents	(7,012,238)	2,243,574
Cash  and cash equivalents at beginning of period	8,077,849	7,127,456
Cash and cash equivalents at end of period	$ 1,065,611	$ 9,371,030

Organization

Organization	6 Months Ended
	Feb. 28, 2023
Accounting Policies [Abstract]
Organization	NOTE 1 – Organization Organization SolarWindow Technologies, Inc. was incorporated in the State of Nevada on May 5, 1998 (“ SWT Company OPV Liquidity and Management’s Plan The Company has not generated any revenue since inception and has sustained recurring losses and negative cash flows from operations since inception. We expect to incur losses as we continue to develop and further refine and promote our technologies and potential product applications. As of February 28, 2023, the Company had $ 7,065,611 7,102,928

Interim Statement Presentation

Interim Statement Presentation	6 Months Ended
	Feb. 28, 2023
Interim Statement Presentation
Interim Statement Presentation	NOTE 2 – Interim Statement Presentation Basis of Presentation and Use of Estimates The accompanying unaudited interim consolidated financial statements of SolarWindow Technologies, Inc. and its controlled subsidiary companies (collectively, the “ Company SEC U.S. GAAP The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying disclosures. Actual results may differ from those estimates. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position as of February 28, 2023, results of operations, stockholders’ equity and cash flows for the three and six months ended February 28, 2023 and 2022. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year. The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. The Company considers its accounting policies relating to stock-based compensation to be the most significant accounting policy that involves management estimates and judgments. The Company has made accounting estimates based on the facts and circumstances available as of the reporting date. Actual amounts could differ from these estimates, and such differences could be material. These consolidated financial statements presented are those of SolarWindow Technologies, Inc. and its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and SolarWindow Asia Co. Ltd. (the “ Korean Subsidiary As more fully described in Note 3, on January 13, 2023, the Board determined that it is in the best interests of the Company to discontinue operations in South Korea and to dissolve the Korean Subsidiary. In accordance with applicable accounting guidance, the results of the Korean Subsidiary are presented as discontinued operations in the Consolidated Statements of Operations and Comprehensive Loss and, as such, have been excluded from continuing operations. Further, the Company reclassified the assets and liabilities of the Korean Subsidiary as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of August 31, 2022. The Consolidated Statements of Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2022. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Financial Statements” in the Annual Report. Fiscal quarter The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s second quarter in fiscal 2023 and 2022 ended on February 28, 2023 and 2022, respectively. Cash and Highly Liquid Investments Cash includes cash on hand and highly liquid investments with original maturities of three months or less from the date of purchase. The Company had $ 7,065,611 118,296 6,946,280 6,872,799 Schedule of cash and highly liquid investments February 28, August 31, Cash $ 1,065,611 $ 8,077,849 Short-term investments 6,000,000 - Total Cash and Short term investments $ 7,065,611 $ 8,077,849 Short-term investments The Company determines the balance sheet classification of its investments at the time of purchase and evaluates the classification at each balance sheet date. Money market funds, certificates of deposit, and time deposits with maturities of greater than three months but no more than twelve months are carried at cost, which approximates fair value and are recorded in the consolidated balance sheets in short-term investments. As of February 28, 2023, short-term investments consists of a 12-month $4,000,000 fixed-term deposit earning interest of 5.3%, a 12-month $1,500,000 fixed term deposit earning interest of 4.25%, and a 6-month $500,000 fixed-term deposit earning interest of 4.85% purchased in February 2023. Accounting Pronouncements The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable, the Company has not identified any standards that the Company believes merit further discussion. Recent accounting pronouncements not yet adopted None. Recently adopted accounting pronouncements None.

Discontinued Operations

Discontinued Operations	6 Months Ended
	Feb. 28, 2023
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	NOTE 3 – Discontinued Operations On January 13, 2023, the Board determined that it is in the best interests of the Company to discontinue operations in South Korea and to dissolve the Korean Subsidiary. The Company is working to dispose the Korean Subsidiary other than by sale in accordance with Accounting Standards Codification (“ASC”) 360-10-45-15, Long-Lived Assets to Be Disposed of Other Than by Sale In accordance with ASC 205-20, Discontinued Operations, the results of the Korean Subsidiary are presented as discontinued operations in the Consolidated Statements of Operations and Comprehensive Loss, and, as such, have been excluded from continuing operations. Further, the Company reclassified the assets and liabilities of the Korean Subsidiary as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of August 31, 2022. The Consolidated Statements of Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. The following table summarizes the significant items included in income from discontinued operations, net of tax in the Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended February 28, 2023 and 2022: Schedule of statement of operations and comprehensive loss Three Months Ended February 28, Six Months Ended February 28, 2023 2022 2023 2022 Operating expenses Selling, general and administrative $ 37,390 $ 155,930 $ 188,266 $ 305,484 Research and development - 45,175 16,253 105,647 Total operating expenses 37,390 201,105 204,519 411,131 Other income Interest income - 59 9 103 Net loss from discontinued operations $ (37,390 ) (201,046 ) $ (204,510 ) $ (411,028 ) The following table summarizes the carrying value of the significant classes of assets and liabilities classified as discontinued operations as of August 31, 2022 and February 28, 2023: Schedule of significant classes of assets and liabilities February 28, 2023 August 31, 2022 Current assets Prepaid expenses and other current assets $ 14,085 $ 43,599 Total current assets 14,085 43,599 Total assets $ 14,085 $ 43,599 Current liabilities Accounts payable and accrued expenses $ 105,490 $ 57,585 Total current liabilities $ 105,490 $ 57,585 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows for all periods presented. Korean Subsidiary depreciation expense for the six months ended February 28, 2023 and 2022, and included in the consolidated statement of cash flow was $ 0 7,532 0 581,648

Net Income (Loss) Per Share

Net Income (Loss) Per Share	6 Months Ended
	Feb. 28, 2023
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	NOTE 4 - Net Income (Loss) Per Share The computation of basic earnings per share (“ EPS The shares listed below were not included in the computation of diluted losses per share because to do so would be antidilutive for the periods presented: Schedule of computation of diluted losses per share Three Months Ended February 28, Six Months Ended February 28, 2023 2022 2023 2022 Stock options 6,707,400 6,781,800 6,707,400 6,781,800 Warrants 16,666,667 19,281,917 16,666,667 19,281,917 23,374,067 26,063,717 23,374,067 26,063,717

Property and Equipment

Property and Equipment	6 Months Ended
	Feb. 28, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment	NOTE 5 – Property and Equipment Property and equipment consists of the following: Schedule of property and equipment February 28, August 31, 2023 2022 Computers, office equipment and software $ 14,102 $ 14,102 Equipment 133,653 133,653 In-process equipment 1,292,655 1,292,655 Total property and equipment 1,440,410 1,440,410 Accumulated depreciation (117,940 ) (110,418 ) Property and equipment, net $ 1,322,470 $ 1,329,992 During the three months ended February 28, 2023 and 2022, the Company recognized straight-line depreciation expense of $ 3,594 7,167 7,521 15,809 During the year ended August 31, 2019, the Company made deposits for in-process equipment totaling $ 1,292,655

Common Stock and Warrants

Common Stock and Warrants	6 Months Ended
	Feb. 28, 2023
Equity [Abstract]
Common Stock and Warrants	NOTE 6 – Common Stock and Warrants Common Stock At February 28, 2023, the Company had 300,000,000 0.001 53,198,399 Warrants Each of the Company’s warrants outstanding entitles the holder to purchase one share of the Company’s common stock for each warrant share held. Other than the Series P Warrants, all of the following warrants may be exercised on a cashless basis. A summary of the Company’s warrants outstanding and exercisable as of February 28, 2023 and August 31, 2022 is as follows: Schedule of warrants Shares of Common Stock Weighted Description February 28, August 31, Exercise Date of Expiration Series M - 246,000 $ 2.34 December 7, 2015 December 31, 2022 Series N - 767,000 $ 3.38 December 31, 2015 December 31, 2022 Series P - 213,500 $ 3.70 March 25, 2016 December 31, 2022 Series R - 468,750 $ 4.00 June 20, 2016 December 31, 2022 Series S-A - 300,000 $ 2.53 July 24, 2017 December 31, 2022 Series S - 620,000 $ 3.42 September 29, 2017 September 29, 2022 Series T 16,666,667 16,666,667 $ 1.70 November 26, 2018 November 26, 2025 Total 16,666,667 19,281,917 During the six months ended February 28, 2023, the Series M, N, P R, S-A and S Warrants expired unexercised.

Stock Options

Stock Options	6 Months Ended
	Feb. 28, 2023
Share-Based Payment Arrangement [Abstract]
Stock Options	NOTE 7 - Stock Options The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimated the grant date fair value of stock options using a Black-Scholes valuation model using the following weighted-average assumptions: Schedule of weighted average assumptions Six Months Ended February 28, 2023 2022 Expected dividend yield - – Expected stock price volatility - 103.31 % Risk-free interest rate - 1.16 % Expected term (in years)(simplified method) - 5.75 Exercise price - $ 6.21 Weighted-average grant date fair-value - $ 4.92 A summary of the Company’s stock option activity for the six months ended February 28, 2023 and related information follows: Schedule of stock option activity Number of Weighted Weighted Aggregate Outstanding at August 31, 2022 6,761,400 4.01 Forfeitures and cancellations (54,000 ) 4.53 Outstanding at February 28, 2023 6,707,400 4.00 2.88 - Exercisable at February 28, 2023 6,646,400 4.01 2.89 - The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their vested options on February 28, 2023. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $ 1.48 1.48 no Three and Six Months Ended February 28, 2022 Grants 140,000 6.21 the Company’s listing of any of its securities for trading on a national stock exchange, ten-year term and vesting as to 50% of the options on the six-month anniversary of the date of grant and as to the remaining 50% of the options on the twelve-month anniversary from the date of grant. Forfeitures and cancellations As a result of his resignation from the Board on November 10, 2021, Mr. Gary Parmar forfeited 58,600 unvested stock options, including 30,000 options granted on October 27, 2021. The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three and six months ended February 28, 2023 and 2022: Schedule of share-based compensation Three Months Ended Six Months Ended Stock compensation expense: 2023 2022 2023 2022 Selling, general and administrative $ 24,022 $ 389,557 $ 94,832 $ 647,187 Research and development 705 21,232 15,095 42,465 Total $ 24,727 $ 410,789 $ 109,927 $ 689,652 As of February 28, 2023, the Company had $ 118,400 1.5 The following table summarizes information about stock options outstanding and exercisable at February 28, 2023: Schedule of stock options outstanding and exercisable Stock Options Outstanding Stock Options Exercisable Exercise Prices Number of Weighted Weighted Number Weighted Weighted 2.32 153,000 6.62 2.32 153,000 6.62 2.32 2.60 2,500,000 3.34 2.60 2,500,000 3.34 2.60 3.42 50,000 3.64 3.42 37,500 3.64 3.42 3.46 35,000 2.85 3.46 35,000 2.85 3.46 3.54 1,249,400 5.59 3.54 12,000,900 5.72 3.54 3.66 1,000,000 0.50 3.66 1,000,000 0.50 3.66 4.87 110,000 4.73 4.87 110,000 4.73 4.87 6.00 800,000 0.50 6.00 800,000 0.50 6.00 6.21 110,000 8.67 6.21 110,000 8.67 6.21 8.00 700,000 0.50 8.00 700,000 0.50 8.00 Total 6,707,400 2.88 4.00 6,646,400 2.89 4.01

Transactions with Related Perso

Transactions with Related Persons	6 Months Ended
	Feb. 28, 2023
Related Party Transactions [Abstract]
Transactions with Related Persons	NOTE 8 - Transactions with Related Persons A related party with respect to the Company is generally defined as any person (and, if a natural person, inclusive of his or her immediate family) (i) that holds 10% or more of the Company’s securities, (ii) that is part of the Company’s management, (iii) that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. On August 7, 2017, the Company appointed Jatinder Bhogal to the Board of directors. Mr. Bhogal has provided consulting services to the Company through his wholly owned company, Vector Asset Management, Inc. (“ VAMI ECA 34,167 0 258,005 0 524,505 Joseph Sierchio, one of the Company’s directors, has maintained his role as the Company’s General Counsel since its inception as Principal of the law firm of Sierchio & Partners, LLP, and then as a Partner with Satterlee Stephens LLP and beginning in August 2020, as Principal of Sierchio Law, LLP pursuant to an engagement letter which provides for an annual fee of $175,000 in exchange for general counsel services. Mr. Sierchio resigned from the Board effective October 22, 2018, and was reappointed on October 1, 2020. Fees for legal services billed by Sierchio Law, LLP while serving as a director totaled $ 43,750 43,750 87,500 87,500 17,083 14,583 2,500 All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Feb. 28, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 9 – Commitments and Contingencies On June 9, 2022, the Company was served the Notice of Civil Claim dated May 16, 2022 (the “ Notice of Claim Application Order

Leases

Leases	6 Months Ended
	Feb. 28, 2023
Leases [Abstract]
Leases	NOTE 10 – Leases On February 26, 2021, the Korean Subsidiary entered into an apartment lease for the purposes of housing foreign personnel. The apartment lease provided for a term of one year beginning March 7, 2021, monthly rent of approximately $950 and a security deposit of approximately $8,700. This lease was terminated in November 2022. In September 2020, the Korean Subsidiary entered a lease for office space. The office lease provided for an initial term of one-year from September 23, 2020 through September 23, 2021, which was been renewed for an additional year, monthly rent of approximately $1,200 and a security deposit of approximately $13,000. This lease was terminated in December 2022. The Company’s policy is to record all leases with a term of less than one year as an operating lease with rent expensed recorded on a straight-line basis and to not recognize lease assets or lease liabilities. As of February 28, 2023, the Company has not entered into any leases other than those described above which have not yet commenced and would entitle the Company to significant rights or create additional obligations.

Subsequent Events

Subsequent Events	6 Months Ended
	Feb. 28, 2023
Subsequent Events [Abstract]
Subsequent Events	NOTE 11 – Subsequent Events Management has reviewed material events subsequent of the period ended February 28, 2023 and through the date of filing of financial statements in accordance with FASB ASC 855 “Subsequent Events”. In managements opinion, no material subsequent events have occurred as of the date of this quarterly report. On March 17, 2023 the 2006 Long-Term Incentive Plan expired.

Interim Statement Presentation

Interim Statement Presentation (Policies)	6 Months Ended
	Feb. 28, 2023
Interim Statement Presentation
Basis of Presentation and Use of Estimates	Basis of Presentation and Use of Estimates The accompanying unaudited interim consolidated financial statements of SolarWindow Technologies, Inc. and its controlled subsidiary companies (collectively, the “ Company SEC U.S. GAAP The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying disclosures. Actual results may differ from those estimates. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position as of February 28, 2023, results of operations, stockholders’ equity and cash flows for the three and six months ended February 28, 2023 and 2022. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year. The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. The Company considers its accounting policies relating to stock-based compensation to be the most significant accounting policy that involves management estimates and judgments. The Company has made accounting estimates based on the facts and circumstances available as of the reporting date. Actual amounts could differ from these estimates, and such differences could be material. These consolidated financial statements presented are those of SolarWindow Technologies, Inc. and its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and SolarWindow Asia Co. Ltd. (the “ Korean Subsidiary As more fully described in Note 3, on January 13, 2023, the Board determined that it is in the best interests of the Company to discontinue operations in South Korea and to dissolve the Korean Subsidiary. In accordance with applicable accounting guidance, the results of the Korean Subsidiary are presented as discontinued operations in the Consolidated Statements of Operations and Comprehensive Loss and, as such, have been excluded from continuing operations. Further, the Company reclassified the assets and liabilities of the Korean Subsidiary as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of August 31, 2022. The Consolidated Statements of Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2022. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Financial Statements” in the Annual Report.
Fiscal quarter	Fiscal quarter The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s second quarter in fiscal 2023 and 2022 ended on February 28, 2023 and 2022, respectively.
Cash and Highly Liquid Investments	Cash and Highly Liquid Investments Cash includes cash on hand and highly liquid investments with original maturities of three months or less from the date of purchase. The Company had $ 7,065,611 118,296 6,946,280 6,872,799 Schedule of cash and highly liquid investments February 28, August 31, Cash $ 1,065,611 $ 8,077,849 Short-term investments 6,000,000 - Total Cash and Short term investments $ 7,065,611 $ 8,077,849
Short-term investments	Short-term investments The Company determines the balance sheet classification of its investments at the time of purchase and evaluates the classification at each balance sheet date. Money market funds, certificates of deposit, and time deposits with maturities of greater than three months but no more than twelve months are carried at cost, which approximates fair value and are recorded in the consolidated balance sheets in short-term investments. As of February 28, 2023, short-term investments consists of a 12-month $4,000,000 fixed-term deposit earning interest of 5.3%, a 12-month $1,500,000 fixed term deposit earning interest of 4.25%, and a 6-month $500,000 fixed-term deposit earning interest of 4.85% purchased in February 2023.
Accounting Pronouncements	Accounting Pronouncements The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable, the Company has not identified any standards that the Company believes merit further discussion. Recent accounting pronouncements not yet adopted None. Recently adopted accounting pronouncements None.

Interim Statement Presentatio_2

Interim Statement Presentation (Tables)	6 Months Ended
	Feb. 28, 2023
Interim Statement Presentation
Schedule of cash and highly liquid investments	Schedule of cash and highly liquid investments February 28, August 31, Cash $ 1,065,611 $ 8,077,849 Short-term investments 6,000,000 - Total Cash and Short term investments $ 7,065,611 $ 8,077,849

Discontinued Operations (Tables

Discontinued Operations (Tables)	6 Months Ended
	Feb. 28, 2023
Discontinued Operations and Disposal Groups [Abstract]
Schedule of significant classes of assets and liabilities	Schedule of statement of operations and comprehensive loss Three Months Ended February 28, Six Months Ended February 28, 2023 2022 2023 2022 Operating expenses Selling, general and administrative $ 37,390 $ 155,930 $ 188,266 $ 305,484 Research and development - 45,175 16,253 105,647 Total operating expenses 37,390 201,105 204,519 411,131 Other income Interest income - 59 9 103 Net loss from discontinued operations $ (37,390 ) (201,046 ) $ (204,510 ) $ (411,028 ) The following table summarizes the carrying value of the significant classes of assets and liabilities classified as discontinued operations as of August 31, 2022 and February 28, 2023: Schedule of significant classes of assets and liabilities February 28, 2023 August 31, 2022 Current assets Prepaid expenses and other current assets $ 14,085 $ 43,599 Total current assets 14,085 43,599 Total assets $ 14,085 $ 43,599 Current liabilities Accounts payable and accrued expenses $ 105,490 $ 57,585 Total current liabilities $ 105,490 $ 57,585 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows for all periods presented. Korean Subsidiary depreciation expense for the six months ended February 28, 2023 and 2022, and included in the consolidated statement of cash flow was $ 0 7,532 0 581,648
Schedule of significant classes of assets and liabilities	Schedule of significant classes of assets and liabilities February 28, 2023 August 31, 2022 Current assets Prepaid expenses and other current assets $ 14,085 $ 43,599 Total current assets 14,085 43,599 Total assets $ 14,085 $ 43,599 Current liabilities Accounts payable and accrued expenses $ 105,490 $ 57,585 Total current liabilities $ 105,490 $ 57,585 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows for all periods presented. Korean Subsidiary depreciation expense for the six months ended February 28, 2023 and 2022, and included in the consolidated statement of cash flow was $ 0 7,532 0 581,648

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	6 Months Ended
	Feb. 28, 2023
Earnings Per Share [Abstract]
Schedule of computation of diluted losses per share	Schedule of computation of diluted losses per share Three Months Ended February 28, Six Months Ended February 28, 2023 2022 2023 2022 Stock options 6,707,400 6,781,800 6,707,400 6,781,800 Warrants 16,666,667 19,281,917 16,666,667 19,281,917 23,374,067 26,063,717 23,374,067 26,063,717

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Feb. 28, 2023
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Schedule of property and equipment February 28, August 31, 2023 2022 Computers, office equipment and software $ 14,102 $ 14,102 Equipment 133,653 133,653 In-process equipment 1,292,655 1,292,655 Total property and equipment 1,440,410 1,440,410 Accumulated depreciation (117,940 ) (110,418 ) Property and equipment, net $ 1,322,470 $ 1,329,992

Common Stock and Warrants (Tabl

Common Stock and Warrants (Tables)	6 Months Ended
	Feb. 28, 2023
Equity [Abstract]
Schedule of warrants	Schedule of warrants Shares of Common Stock Weighted Description February 28, August 31, Exercise Date of Expiration Series M - 246,000 $ 2.34 December 7, 2015 December 31, 2022 Series N - 767,000 $ 3.38 December 31, 2015 December 31, 2022 Series P - 213,500 $ 3.70 March 25, 2016 December 31, 2022 Series R - 468,750 $ 4.00 June 20, 2016 December 31, 2022 Series S-A - 300,000 $ 2.53 July 24, 2017 December 31, 2022 Series S - 620,000 $ 3.42 September 29, 2017 September 29, 2022 Series T 16,666,667 16,666,667 $ 1.70 November 26, 2018 November 26, 2025 Total 16,666,667 19,281,917

Stock Options (Tables)

Stock Options (Tables)	6 Months Ended
	Feb. 28, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of weighted average assumptions	Schedule of weighted average assumptions Six Months Ended February 28, 2023 2022 Expected dividend yield - – Expected stock price volatility - 103.31 % Risk-free interest rate - 1.16 % Expected term (in years)(simplified method) - 5.75 Exercise price - $ 6.21 Weighted-average grant date fair-value - $ 4.92
Schedule of stock option activity	Schedule of stock option activity Number of Weighted Weighted Aggregate Outstanding at August 31, 2022 6,761,400 4.01 Forfeitures and cancellations (54,000 ) 4.53 Outstanding at February 28, 2023 6,707,400 4.00 2.88 - Exercisable at February 28, 2023 6,646,400 4.01 2.89 -
Schedule of share-based compensation	Schedule of share-based compensation Three Months Ended Six Months Ended Stock compensation expense: 2023 2022 2023 2022 Selling, general and administrative $ 24,022 $ 389,557 $ 94,832 $ 647,187 Research and development 705 21,232 15,095 42,465 Total $ 24,727 $ 410,789 $ 109,927 $ 689,652
Schedule of stock options outstanding and exercisable	Schedule of stock options outstanding and exercisable Stock Options Outstanding Stock Options Exercisable Exercise Prices Number of Weighted Weighted Number Weighted Weighted 2.32 153,000 6.62 2.32 153,000 6.62 2.32 2.60 2,500,000 3.34 2.60 2,500,000 3.34 2.60 3.42 50,000 3.64 3.42 37,500 3.64 3.42 3.46 35,000 2.85 3.46 35,000 2.85 3.46 3.54 1,249,400 5.59 3.54 12,000,900 5.72 3.54 3.66 1,000,000 0.50 3.66 1,000,000 0.50 3.66 4.87 110,000 4.73 4.87 110,000 4.73 4.87 6.00 800,000 0.50 6.00 800,000 0.50 6.00 6.21 110,000 8.67 6.21 110,000 8.67 6.21 8.00 700,000 0.50 8.00 700,000 0.50 8.00 Total 6,707,400 2.88 4.00 6,646,400 2.89 4.01

Organization (Details Narrative

Organization (Details Narrative)	Feb. 28, 2023 USD ($)
Accounting Policies [Abstract]
Cash and cash equivalents	$ 7,065,611
Working capital	$ 7,102,928

Interim Statement Presentatio_3

Interim Statement Presentation (Details) - USD ($)	Feb. 28, 2023	Aug. 31, 2022
Interim Statement Presentation
Cash	$ 1,065,611	$ 8,077,849
Short-term investments	6,000,000
Total Cash and Short term investments	$ 7,065,611	$ 8,077,849

Interim Statement Presentatio_4

Interim Statement Presentation (Details Narrative) - USD ($)	6 Months Ended
	Feb. 28, 2023	Aug. 31, 2022
Schedule of Investments [Line Items]
Cash held in investments	$ 7,065,611	$ 8,077,849
Short term investment description	As of February 28, 2023, short-term investments consists of a 12-month $4,000,000 fixed-term deposit earning interest of 5.3%, a 12-month $1,500,000 fixed term deposit earning interest of 4.25%, and a 6-month $500,000 fixed-term deposit earning interest of 4.85% purchased in February 2023.
U S Investments [Member]
Schedule of Investments [Line Items]
Cash held in investments	$ 7,065,611
FDIC Insured amount	118,296
Canadian Deposits [Member]
Schedule of Investments [Line Items]
Cash held in investments	6,946,280
FDIC Insured amount	$ 6,872,799

Discontinued Operations (Detail

Discontinued Operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2023	Feb. 28, 2022
Operating expenses
Selling, general and administrative	$ 37,390	$ 155,930	$ 188,266	$ 305,484
Research and development		45,175	16,253	105,647
Total operating expenses	37,390	201,105	204,519	411,131
Other income
Interest income		59	9	103
Net loss from discontinued operations	$ (37,390)	$ (201,046)	$ (204,510)	$ (411,028)

Discontinued Operations (Deta_2

Discontinued Operations (Details 1) - USD ($)	Feb. 28, 2023	Aug. 31, 2022
Current assets
Prepaid expenses and other current assets	$ 14,085	$ 43,599
Total current assets	14,085	43,599
Total assets	14,085	43,599
Current liabilities
Accounts payable and accrued expenses	105,490	57,585
Total current liabilities	$ 105,490	$ 57,585

Discontinued Operations (Deta_3

Discontinued Operations (Details Narrative) - USD ($)	6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Discontinued Operations and Disposal Groups [Abstract]
Depreciation expense discontinued operations	$ 0	$ 7,532
Capital expenditures	$ 0	$ 581,648

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2023	Feb. 28, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	23,374,067	26,063,717	23,374,067	26,063,717
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	6,707,400	6,781,800	6,707,400	6,781,800
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	16,666,667	19,281,917	16,666,667	19,281,917

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Feb. 28, 2023	Aug. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 1,440,410	$ 1,440,410
Accumulated depreciation	(117,940)	(110,418)
Property and equipment, net	1,322,470	1,329,992
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	14,102	14,102
Equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	133,653	133,653
In Process Equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 1,292,655	$ 1,292,655

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2023	Feb. 28, 2022	Aug. 31, 2022	Aug. 31, 2019
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 3,594	$ 7,167	$ 7,521	$ 15,809
Deposits for in-process equipment	$ 1,440,410		$ 1,440,410		$ 1,440,410
In Process Equipments [Member]
Property, Plant and Equipment [Line Items]
Deposits for in-process equipment						$ 1,292,655

Common Stock and Warrants (Deta

Common Stock and Warrants (Details) - $ / shares	6 Months Ended
	Feb. 28, 2023	Aug. 31, 2022
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding	16,666,667	19,281,917
Series M [Member]
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding		246,000
Weighted Average Exercise Price	$ 2.34
Date of Issuance	Dec. 07, 2015
Expiration	Dec. 31, 2022
Series N [Member]
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding		767,000
Weighted Average Exercise Price	$ 3.38
Date of Issuance	Dec. 31, 2015
Expiration	Dec. 31, 2022
Series P [Member]
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding		213,500
Weighted Average Exercise Price	$ 3.70
Date of Issuance	Mar. 25, 2016
Expiration	Dec. 31, 2022
Series R [Member]
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding		468,750
Weighted Average Exercise Price	$ 4
Date of Issuance	Jun. 20, 2016
Expiration	Dec. 31, 2022
Series S A [Member]
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding		300,000
Weighted Average Exercise Price	$ 2.53
Date of Issuance	Jul. 24, 2017
Expiration	Dec. 31, 2022
Series S [Member]
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding		620,000
Weighted Average Exercise Price	$ 3.42
Date of Issuance	Sep. 29, 2017
Expiration	Sep. 29, 2022
Series T [Member]
Class of Stock [Line Items]
Shares of Common Stock Issuable from Warrants Outstanding	16,666,667	16,666,667
Weighted Average Exercise Price	$ 1.70
Date of Issuance	Nov. 26, 2018
Expiration	Nov. 26, 2025

Common Stock and Warrants (De_2

Common Stock and Warrants (Details Narrative) - $ / shares	Feb. 28, 2023	Aug. 31, 2022
Equity [Abstract]
Common stock, shares authorized	300,000,000	300,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares outstanding	53,198,399	53,198,399

Stock Options (Details)

Stock Options (Details) - Equity Option [Member] - USD ($)	6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividend yield
Expected stock price volatility		103.31%
Risk-free interest rate		1.16%
Expected term (in years)(simplified method)		5 years 9 months
Exercise price		$ 6.21
Weighted-average grant date fair-value		$ 4.92

Stock Options (Details 1)

Stock Options (Details 1) - Equity Option [Member]	6 Months Ended
	Feb. 28, 2023 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares Subject to Option Grants, Outstanding Balance, Beginning | shares	6,761,400
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares	$ 4.01
Number of Shares Subject to Option Grants, forfeitures and cancellations | shares	(54,000)
Weighted Average Exercise Price, forfeitures and cancellations | $ / shares	$ 4.53
Number of Shares Subject to Option Grants, Outstanding Balance, Ending | shares	6,707,400
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	$ 4
Weighted Average Remaining Contractual Term, Outstanding	2 years 10 months 17 days
Aggregate Intrinsic Value Outstanding | $
Number of Shares Subject to Option Grants, Exercisable | shares	6,646,400
Weighted Average Exercise Price, Exercisable | $ / shares	$ 4.01
Weighted Average Remaining Contractual Term, Exercisable	2 years 10 months 20 days
Aggregate Intrinsic Value Exercisable | $

Stock Options (Details 2)

Stock Options (Details 2) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2023	Feb. 28, 2022
Stock compensation expense:
Selling, general and administrative	$ 24,022	$ 389,557	$ 94,832	$ 647,187
Research and development	705	21,232	15,095	42,465
Total	$ 24,727	$ 410,789	$ 109,927	$ 689,652

Stock Options (Details 3)

Stock Options (Details 3)	6 Months Ended
	Feb. 28, 2023 $ / shares shares
Equity Option [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	6,707,400
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	2 years 10 months 17 days
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 4
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	6,646,400
Stock Options Exercisable Weighted Average Contractural Life (Years)	2 years 10 months 20 days
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 4.01
$2.32 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	153,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	6 years 7 months 13 days
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 2.32
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	153,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	6 years 7 months 13 days
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 2.32
$2.60 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	2,500,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	3 years 4 months 2 days
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 2.60
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	2,500,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	3 years 4 months 2 days
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 2.60
$3.42 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	50,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	3 years 7 months 20 days
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 3.42
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	37,500
Stock Options Exercisable Weighted Average Contractural Life (Years)	3 years 7 months 20 days
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 3.42
$3.46 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	35,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	2 years 10 months 6 days
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 3.46
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	35,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	2 years 10 months 6 days
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 3.46
$3.54 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	1,249,400
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	5 years 7 months 2 days
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 3.54
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	12,000,900
Stock Options Exercisable Weighted Average Contractural Life (Years)	5 years 8 months 19 days
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 3.54
$3.66 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	1,000,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	6 months
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 3.66
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	1,000,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	6 months
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 3.66
$4.87 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	110,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	4 years 8 months 23 days
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 4.87
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	110,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	4 years 8 months 23 days
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 4.87
$6.00 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	800,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	6 months
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 6
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	800,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	6 months
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 6
$6.21 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	110,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	8 years 8 months 1 day
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 6.21
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	110,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	8 years 8 months 1 day
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 6.21
$8.00 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding Number of Shares Subject to Outstanding Options | shares	700,000
Stock Options Outstanding Number of Shares Subject to Outstanding Options Weighted Average Contractural Life (years)hted Average Contractural Life (years)	6 months
Stock Options Outstanding Weighted Average Exercise Price | $ / shares	$ 8
Stock Options Exercisable Number of Shares Subject To Options Exercisable | shares	700,000
Stock Options Exercisable Weighted Average Contractural Life (Years)	6 months
Stock Options Exercisable Weighted Average Exercise Price | $ / shares	$ 8

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)		6 Months Ended
	Oct. 27, 2021	Feb. 28, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option exercise price		$ 1.48
Stock option description		As a result of his resignation from the Board on November 10, 2021, Mr. Gary Parmar forfeited 58,600 unvested stock options, including 30,000 options granted on October 27, 2021.
Officers and Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options granted	140,000
Option exercise price	$ 6.21
Stock option, description	the Company’s listing of any of its securities for trading on a national stock exchange, ten-year term and vesting as to 50% of the options on the six-month anniversary of the date of grant and as to the remaining 50% of the options on the twelve-month anniversary from the date of grant.
Equity Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Closing stock option exercise price		$ 1.48
Aggregate intrinsic value of options vested		$ 0
Share based compensation expenses not yet recognized		$ 118,400
Share based compensation recognition period		1 year 6 months

Transactions with Related Per_2

Transactions with Related Persons (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
	Jan. 18, 2022	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2023	Feb. 28, 2022
VAMI [Member]
Related Party Transaction [Line Items]
Cash compensation expense		$ 0	$ 258,005	$ 0	$ 524,505
Satterlee Stephens L L P [Member]
Related Party Transaction [Line Items]
Legal service fee		43,750	$ 43,750	87,500	$ 87,500
Sierchio Law L L P [Member]
Related Party Transaction [Line Items]
Legal service fee		14,583
Related party payable		17,083		$ 17,083
Board fee		$ 2,500
Consulting Agreement [Member] | VAMI [Member]
Related Party Transaction [Line Items]
Share based compensation monthly	$ 34,167

Leases (Details Narrative)

Leases (Details Narrative)	6 Months Ended
	Feb. 28, 2023
Rent description	The apartment lease provided for a term of one year beginning March 7, 2021, monthly rent of approximately $950 and a security deposit of approximately $8,700. This lease was terminated in November 2022.
Office Space [Member]
Rent description	The office lease provided for an initial term of one-year from September 23, 2020 through September 23, 2021, which was been renewed for an additional year, monthly rent of approximately $1,200 and a security deposit of approximately $13,000. This lease was terminated in December 2022.